ZVSA
ZyVersa Therapeutics, Inc.Company with tickers: ZVSA
CIK
1859007
CUSIP
98987D300
Shares Outstanding
8,095,921
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-07-11 | Park Min-Chul |
Director | Award | 11,066 |
| 2025-07-11 | Cashmere Karen A. |
Chief Commercial Officer | Award | 48,100 |
| 2025-07-11 | Glover Stephen C. |
Director | Award | 136,900 |
| 2025-07-11 | Finizio Robert G |
Director | Award | 11,066 |
| 2025-07-11 | Guzman Pablo A. |
Chief Medical Officer | Award | 48,900 |
| 2025-07-11 | Wolfe Peter |
Chief Financial Officer | Award | 60,100 |
| 2025-07-11 | SAPIRSTEIN JAMES |
Director | Award | 11,066 |
| 2025-07-11 | Freitag Gregory Gene |
Director | Award | 11,066 |
| 2023-05-24 | Park Min-Chul |
Director | Award | 132 |
| 2023-05-24 | Wolfe Peter |
Chief Financial Officer | Award | 715 |
| 2023-05-24 | Finizio Robert G |
Director | Award | 132 |
| 2023-05-24 | Freitag Gregory Gene |
Director | Award | 132 |
| 2023-05-24 | SAPIRSTEIN JAMES |
Director | Award | 132 |
| 2023-05-24 | Cashmere Karen A. |
Chief Commercial Officer | Award | 572 |
| 2023-05-24 | Glover Stephen C. |
Director | Award | 1,627 |
| 2023-05-10 | INCON Co., Ltd. |
10% Owner | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 26,021 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Other | 0 |
| 2023-01-26 | Guzman Pablo A. |
Chief Medical Officer | Award | 100,000 |
| 2023-01-05 | Freitag Gregory Gene |
Director | Other | 0 |
| 2023-01-05 | Rupalla Katrin |
Director | Other | 0 |
| 2023-01-05 | SAPIRSTEIN JAMES |
Director | Other | 0 |
| 2022-12-16 | Wolfe Peter |
Chief Financial Officer | Award | 3,000 |
| 2022-12-12 | Cashmere Karen A. |
Chief Commercial Officer | Other | 0 |
| 2022-12-12 | LaBella Nicholas A. Jr. |
Chief Scientific Officer | Award | 39,708 |
| 2022-12-12 | Glover Stephen C. |
Director | Award | 264,838 |
| 2022-12-12 | O'Connor Daniel J. |
Director | Other | 177,204 |
| 2022-12-12 | Glover Stephen C. |
Director | Award | 18 |
| 2022-12-12 | Glover Stephen C. |
Director | Award | 79,417 |
| 2022-12-12 | Park Min-Chul |
Director | Award | 29,781 |
| 2022-12-12 | Finizio Robert G |
Director | Award | 19,854 |
| 2022-12-12 | Glover Stephen C. |
Director | Award | 126,138 |
| 2022-12-12 | Wolfe Peter |
Chief Financial Officer | Award | 9,927 |
| 2022-12-12 | Wolfe Peter |
Chief Financial Officer | Award | 39,708 |
| 2022-12-12 | LaBella Nicholas A. Jr. |
Chief Scientific Officer | Award | 18,094 |
| 2022-12-12 | Wolfe Peter |
Chief Financial Officer | Award | 9,927 |
| 2022-12-12 | Glover Stephen C. |
Director | Other | 0 |
| 2022-12-12 | Glover Stephen C. |
Director | Award | 49,636 |
| 2022-12-12 | LaBella Nicholas A. Jr. |
Chief Scientific Officer | Award | 18,094 |
Showing 1–50 of 107 transactions